Humanized L243 antibodies
Humanized antibodies are provided that specifically bind HLA-DR. The antibodies recognize the epitope recognized by the murine monoclonal antibody L243. Processes for preparing such antibodies, pharmaceutical compositions containing such antibodies, and clinical therapuetic and diagnostic, as well as research-related uses for such antibodies, are provided.
Immunomedics, Inc.
C C A C A C C A C A C C C A A A A A C C A C C C C A A A A A A A
C07K C07K A61K C07K A61P C07K C07K A61P C07K A61K C07K C07K C07K A61K A61P A61K A61P A61P C07K C07K A61K C07K C07K C07K C07K A61K A61P A61K A61P A61P A61K A61K
additional inventional inventional additional inventional additional additional inventional inventional inventional additional additional inventional inventional inventional additional inventional inventional additional inventional inventional inventional additional additional additional inventional inventional inventional inventional inventional inventional additional
Chein-Hsing Zhengxing David M. Hans J.
Chang Qu Goldenberg Hansen